1606 Corp. announced on March 17, 2026, the execution of a Purchase and Sale Agreement to acquire a 132-acre property in Lufkin, Texas. This property includes an existing power generation facility and infrastructure suitable for large-scale data center development. The company has filed a press release detailing this a...

On March 11, 2026, Suzanne Seandel informed 8x8, Inc. of her intention to resign as Chief Accounting Officer and principal accounting officer, with a mutually agreed separation date expected in mid-April 2026. Her resignation is not due to any disagreements with the company. 8x8, Inc. will begin searching for her succe...

Abeona Therapeutics Inc. reported its financial results for the full year ended December 31, 2025. The company generated total revenue of $5.8 million, comprising $3.4 million in license and other revenues and $2.4 million in net product revenue. The net product revenue reflects a single patient treatment with ZEVASKYN...

Addentax Group Corp. announced on March 17, 2026, that it has entered into advanced negotiations to acquire several online lending companies in the Asia Pacific region. These companies specialize in AI-supported credit assessment, digital asset-related financial services, and personal digital lending. The potential acq...

Aethlon Medical, Inc. reported that as of the close of business on March 16, 2026, there were 1,569,110 shares of common stock outstanding. This figure reflects the recent exercises of certain pre-funded warrants, resulting in the full exercise of all previously outstanding pre-funded warrants. The company filed this r...

On March 9, 2026, American Rebel Holdings, Inc. entered into a Securities Purchase Agreement with 1800 Diagonal Lending, LLC, resulting in a loan of $124,200. The net proceeds to the company were $100,000 after an original issue discount and fees. Repayment is scheduled in fifteen installments starting April 15, 2026. ...

AN2 Therapeutics reported its financial results for the fourth quarter and full year ended December 31, 2025. The company plans to advance its oral epetraborole into a Phase 2 study for polycythemia vera (PV) in Q3 2026, with potential data readouts in late 2026 and throughout 2027. Enrollment for a Phase 2 investigato...

AptarGroup, Inc. announced a leadership transition plan. Stephan Tanda, the current President and CEO, will retire effective September 1, 2026. Following his retirement, Gael Touya, currently President of the Aptar Pharma segment, will assume the roles of President and CEO. Mr. Touya is also expected to join the Board ...

This Form 8-K filing by Artelo Biosciences, Inc. details a one-for-three reverse stock split effective March 10, 2026. This action reduced the number of outstanding common shares and authorized shares. The filing also incorporates by reference the company's audited financial statements for the fiscal years ending Decem...

Ashford Hospitality Trust, Inc. (the "Company") has entered into a Limited Waiver Under Advisory Agreement with Ashford Hospitality Limited Partnership, Ashford TRS Corporation, Ashford Inc., and Ashford Hospitality Advisors LLC. This waiver, effective March 13, 2026, allows the Company to award cash incentive compensa...

Auburn National Bancorporation, Inc. announced on March 17, 2026, that its Board of Directors has approved a new stock repurchase program. This program authorizes the repurchase of up to $5 million of the Company's issued and outstanding common stock. The repurchases will continue through the earliest of the expenditur...

Academy Sports and Outdoors, Inc. reported its financial results for the fiscal year ended January 31, 2026. The company announced a 2.5% increase in net sales for the fourth quarter, reaching $1.7185 billion, and a 2.0% increase for the full fiscal year, totaling $6.0534 billion. Comparable sales saw a decline of 1.6%...

On March 16, 2026, Advantage Solutions Inc. held a special meeting of stockholders where Proposal 1, to approve amendments to the Company’s Third Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Class A common stock at a ratio ranging from 1-for-10 to 1-for-25, was approved. Prop...

Agassi Sports Entertainment Corp. has entered into two Subscription Agreements with accredited investors, selling an aggregate of 80,000 shares of restricted common stock at $5.00 per share, totaling $400,000. One investor, the Boreta Lifetime Trust, managed by CEO Ronald S. Boreta, purchased 50,000 shares for $250,000...

Akari Therapeutics, Plc announced a change in the ratio of its American Depositary Shares (ADSs) to ordinary shares, from one ADS representing 2,000 ordinary shares to one ADS representing 80,000 ordinary shares. This change, effective March 31, 2026, is intended to help the company comply with the Nasdaq minimum bid p...

Aldeyra Therapeutics announced on March 17, 2026, that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for reproxalap, an investigational drug for dry eye disease. The FDA cited a "lack of substantial evidence" from adequate and well...

Alexander & Baldwin (A&B) announced the completion of its acquisition by a joint venture of MW Group, Blackstone Real Estate, and DivcoWest in an all-cash transaction valued at approximately $2.3 billion, including debt. The transaction, approved by A&B shareholders on March 9, 2026, resulted in A&B becoming a private ...

Allegiant Travel Company ("Allegiant") is presenting at the J.P. Morgan Industrials Conference on March 17, 2026, and has provided an update to its first quarter 2026 financial guidance. Despite an anticipated 5.5% year-over-year decrease in system capacity, Allegiant expects record total revenue for the first quarter ...

On March 17, 2026, American National Group Inc. announced that its Board of Directors has declared a cash dividend for its Series D Preferred Stock. The dividend amounts to $460.9375 per share, which is equivalent to $0.4609375 per depositary share. This dividend will be distributed on April 15, 2026, to shareholders w...

Andersen Group Inc. reported strong financial results for the fourth quarter and full year ended December 31, 2025. Full-year revenue increased by 14.6% to $838.7 million, with fourth-quarter revenue up 19.6% year-over-year to $170.3 million. Despite a net loss for the full year driven by IPO-related expenses, adjusted...

The Arena Group Holdings, Inc. announced its financial results for the quarter and year ended December 31, 2025. The company reported a full-year revenue increase to $134.8 million in 2025 from $125.9 million in 2024, driven by growth in non-advertising revenue streams. The full-year gross margin significantly expanded...

ArriVent BioPharma, Inc. announced that it will present two preclinical posters at the 2026 AACR Annual Meeting. The first poster will detail findings for the EGFR inhibitor firmonertinib, highlighting structural data that supports its ongoing Phase 3 study for EGFR exon 20 insertion mutant non-small cell lung cancer (...

This report details Arthur J. Gallagher & Co. (the "Company") announcing plans to host an investor meeting on Tuesday, March 17, 2026. A webcast of the meeting and related presentation materials, including an updated "CFO Commentary," are available through the investor relations page of the Company's website. The CFO C...

Artificial Intelligence Technology Solutions, Inc. (AITX), through its subsidiary Robotic Assistance Devices, Inc. (RAD), announced an order for ten RIO™ Mini autonomous solar-powered security towers with SARA™ licenses from a major Midwest construction company. These units will be deployed at a government facility con...

On March 13, 2026, Aterian, Inc. entered into Amendment No. 5 to its Credit and Security Agreement dated December 22, 2021. The amendment, effective March 13, 2026, reduces the Minimum Credit Party Liquidity covenant to $3.5 million, applicable through April 12, 2026. This reduction can be extended weekly by the Compan...